Skip to content
buyWeak

Jonathan Finn bought $44k of ATOS

director at ATOSSA THERAPEUTICS, INC.. 25,000 shares at an average of $1.77, traded Apr 10, 2024, filed Apr 11, 2024.

Conviction score
33
Value
$44k
25,000 shares
Holdings after
25,000
change unknown
From 52-week low
+192%
low $9.00, close $26.25
From 52-week high
-17%
high $31.50, as of Apr 10, 2024

Score components

  • Role
    Director
    +15
  • Trade size
    $44k at market
    +6
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    17% below the 52-week high
    +4
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -15.8%, 3m -27.7%, 6m -21.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ATOSOct 12, 2026 · close 2.39
Since filing Apr 11, 2024: -91.0%SPY +54.6% · excess -145.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-24-043690, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 10, 2024POpen-market purchase
Common Stock
+25,000$1.77$44k25,000Apr 11, 2024

Related signals

Other insiders at ATOSSA THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
ATOSbuy
ATOSSA THERAPEUTICS, INC.
Steven C Quay
President & CEO
$9,887
11,239 shares
+423%
25Weak
ATOSbuy
ATOSSA THERAPEUTICS, INC.
H. Lawrence Remmel
director
$7,000
10,000 shares
+3891%
48Moderate
ATOSsell
ATOSSA THERAPEUTICS, INC.
Gregory L Weaver
Former EVP, CFO, & Director
$33k
50,000 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jonathan Finn bought $44k of ATOS | InsiderTell